Literature DB >> 18475510

Inhibition of smooth muscle contraction and platelet aggregation by peptide 204-212 of lipocortin 5: an attempt to define some structure requirements.

K G Mugridge1, C Becherucci, L Parente, M Perretti.   

Abstract

Peptide 204-212 of lipocortin (LC) 5 inhibited porcine pancreatic phospholipase A(2) (PLA(2)) induced rat stomach strip contractions and ADP induced rabbit platelet aggregation in a concentration dependent manner (IC(30) of 10 muM and 400 muM, respectively). The first two amino acids are not necessary since the eptapeptide 206-212 was equipotent in both assays (IC(30) of 12.5 muM and 420 muM). Of the two pentapeptides 204-208 and 208-212 only the latter showed inhibitory activity in both models although the potency was much reduced (IC(30) of 170 muM and 630 muM) compared with that of the parent nonapeptide. Comparison of peptide 204-212 effects with those of its analogues on LC1 and LC2 indicate that lysine 208 and aspartic acid 211 are essential in order to maintain a fully active nonapeptide.

Entities:  

Year:  1993        PMID: 18475510      PMCID: PMC2365395          DOI: 10.1155/S0962935193000146

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  16 in total

1.  Peptide 204-212 of lipocortin 5 inhibits the generation of a prostacyclin-like factor from rat aorta preparations in vitro.

Authors:  G J Douglas; R J Flower; L Parente; M Perretti
Journal:  Prostaglandins       Date:  1992-11

2.  Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.

Authors:  C Tetta; G Camussi; F Bussolino; K Herrick-Davis; C Baglioni
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

3.  Amino acid sequence analysis of the annexin super-gene family of proteins.

Authors:  G J Barton; R H Newman; P S Freemont; M J Crumpton
Journal:  Eur J Biochem       Date:  1991-06-15

4.  The functional site of placental anticoagulant protein: essential histidine residue of placental anticoagulant protein.

Authors:  T Funakoshi; M Abe; M Sakata; S Shoji; Y Kubota
Journal:  Biochem Biophys Res Commun       Date:  1990-04-16       Impact factor: 3.575

Review 5.  Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids?

Authors:  L Parente; C Becherucci; M Perretti; E Solito; K G Mugridge; C L Galeotti; G Raugei; M Melli; M Sanso
Journal:  Prog Clin Biol Res       Date:  1990

6.  Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.

Authors:  F Cabré; J J Moreno; A Carabaza; E Ortega; D Mauleón; G Carganico
Journal:  Biochem Pharmacol       Date:  1992-08-04       Impact factor: 5.858

7.  In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.

Authors:  S Lloret; J J Moreno
Journal:  Biochem Pharmacol       Date:  1992-10-06       Impact factor: 5.858

8.  Effects of antiflammins on endotoxin-induced uveitis in rats.

Authors:  C C Chan; M Ni; L Miele; E Cordella-Miele; M Ferrick; A B Mukherjee; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1991-02

9.  Novel anticoagulant peptides from the functional site of human placental anticoagulant protein.

Authors:  T Funakoshi; M Abe; M Sakata; S Shoji; Y Kubota; H Shimada; S Kojima
Journal:  Biochem Int       Date:  1991-05

10.  A novel anti-inflammatory peptide from human lipocortin 5.

Authors:  M Perretti; C Becherucci; K G Mugridge; E Solito; S Silvestri; L Parente
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.